Glycemic variability and muscle loss in elderly type 2 diabetes: insights from continuous glucose monitoring and chest CT in 303 patients - Scorecard - MDSpire

Glycemic variability and muscle loss in elderly type 2 diabetes: insights from continuous glucose monitoring and chest CT in 303 patients

  • By

  • Xiao-le Zhang

  • Ning Bai

  • Chun-pu Mao

  • Chun-yan Liu

  • June 22, 2026

  • 0 min

Share

Clinical Scorecard: Association of Glycemic Fluctuations with Muscle Mass Loss in Older Adults with Type 2 Diabetes: Findings from Continuous Glucose Monitoring and Chest CT in 303 Patients

At a Glance

CategoryDetail
ConditionType 2 Diabetes Mellitus (T2DM)
Key MechanismsGlycemic variability and its impact on muscle mass
Target PopulationElderly patients aged ≥ 60 years with T2DM
Care SettingEndocrinology department in a hospital setting

Key Highlights

  • Glycemic variability indicators (CV, SD, MAGE, TBR) associated with lower pectoralis muscle mass.
  • CV explained the largest proportion of variance in pectoralis muscle index (PMI).
  • Stronger inverse association found in patients with diabetes duration ≥ 10 years and BMI < 24 kg/m².
  • Continuous glucose monitoring provides detailed glycemic control insights beyond HbA1c.
  • Pectoralis muscle index (PMI) correlates well with total skeletal muscle mass.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of T2DM according to WHO criteria.

Management

  • Consider stabilizing glucose fluctuations to preserve muscle mass.

Monitoring & Follow-up

  • Utilize continuous glucose monitoring for assessing glycemic variability.

Risks

  • Increased risk of muscle mass loss associated with greater glycemic variability.

Patient & Prescribing Data

Elderly patients with T2DM, aged ≥ 60 years.

Focus on managing glycemic variability to mitigate muscle loss.

Clinical Best Practices

  • Integrate continuous glucose monitoring in clinical practice for older adults with T2DM.
  • Use chest CT scans opportunistically for assessing muscle mass in patients undergoing imaging for other reasons.

Related Resources & Content

Original Source(s)

Glycemic variability and muscle loss in elderly type 2 diabetes: insights from continuous glucose monitoring and chest CT in 303 patients

  • by Xiao-le Zhang, Ning Bai, Chun-pu Mao, Chun-yan Liu

  • June 22, 2026

Related Content

Staging and Practical Management of Diabetic Retinopathy

Approximately half of patients who have severe NPDR and nearly 75% of patients who have very severe NPDR will progress to PDR within 1 year.

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.